Literature DB >> 22552781

D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity.

Michael Y Aksenov1, M V Aksenova, C F Mactutus, Rosemarie M Booze.   

Abstract

The interactive effects of HIV-1 infection and methamphetamine (METH) abuse in producing cognitive dysfunction represent a serious medical problem; however, the neural mechanisms underlying this interactive neurotoxicity remain elusive. In this study, we report that a combination of low, sub-toxic doses of METH + HIV-1 Tat 1-86 B, but not METH + HIV-1 gp120, directly induces death of rodent midbrain neurons in vitro. The effects of D1- and NMDA-receptor specific antagonists (SCH23390 and MK-801, respectively) on the neurotoxicity of different doses of METH or HIV-1 Tat alone and on the METH + HIV-1Tat interaction in midbrain neuronal cultures suggest that the induction of the cell death cascade by METH and Tat requires both dopaminergic (D1) and N-methyl D-aspartate (NMDA) receptor-mediated signaling. This interactive METH+Tat neurotoxicity does not occur in cultures of hippocampal neurons, which are predominately glutamatergic, express very low levels of dopamine receptors, and have no functional dopamine transporter (DAT). Thus, the presence of a subpopulation of neurons capable of dopamine release/uptake is essential for METH+Tat induction of the cell death cascade. Overall, our results support the hypothesis that METH and HIV-1 Tat disrupt the normal conjunction of signaling between D1 and NMDA receptors, resulting in neural dysfunction and death.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552781      PMCID: PMC4041990          DOI: 10.1007/s11481-012-9362-3

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  77 in total

1.  Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.

Authors:  A H Shin; H J Kim; S A Thayer
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 2.  Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex.

Authors:  Stacy A Castner; Graham V Williams
Journal:  Brain Cogn       Date:  2007-01-03       Impact factor: 2.310

Review 3.  Health outcomes associated with methamphetamine use among young people: a systematic review.

Authors:  Brandon D L Marshall; Daniel Werb
Journal:  Addiction       Date:  2010-06       Impact factor: 6.526

4.  Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death.

Authors:  Arthi Kanthasamy; V Anantharam; Syed F Ali; A G Kanthasamy
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

5.  Methamphetamine abuse, HIV infection, and neurotoxicity.

Authors:  Benjamin C Reiner; James P Keblesh; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-09-25

6.  HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.

Authors:  Jun Zhu; Charles F Mactutus; David R Wallace; Rosemarie M Booze
Journal:  J Pharmacol Exp Ther       Date:  2009-03-26       Impact factor: 4.030

7.  The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study.

Authors:  M J Ferris; D Frederick-Duus; J Fadel; C F Mactutus; R M Booze
Journal:  Neuroscience       Date:  2009-01-20       Impact factor: 3.590

8.  Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120.

Authors:  Amanda J Roberts; Ricky Maung; Natalia E Sejbuk; Christopher Ake; Marcus Kaul
Journal:  J Neurosci Methods       Date:  2009-11-13       Impact factor: 2.390

9.  Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain.

Authors:  Govinder Flora; Yong Woo Lee; Avindra Nath; Bernhard Hennig; William Maragos; Michal Toborek
Journal:  Exp Neurol       Date:  2003-01       Impact factor: 5.330

10.  Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum.

Authors:  Emily L Jocoy; Véronique M André; Damian M Cummings; Shilpa P Rao; Nanping Wu; Amy J Ramsey; Marc G Caron; Carlos Cepeda; Michael S Levine
Journal:  Front Syst Neurosci       Date:  2011-05-11
View more
  14 in total

1.  Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.

Authors:  Changqing Xu; Douglas J Hermes; Blessing Nwanguma; Ian R Jacobs; Kenneth Mackie; Somnath Mukhopadhyay; Aron H Lichtman; Bogna Ignatowska-Jankowska; Sylvia Fitting
Journal:  Mol Cell Neurosci       Date:  2017-07-19       Impact factor: 4.314

2.  Network analysis of hippocampal neurons by microelectrode array in the presence of HIV-1 Tat and cocaine.

Authors:  Taha Mohseni Ahooyi; Masoud Shekarabi; Emilie A Decoppet; Dianne Langford; Kamel Khalili; Jennifer Gordon
Journal:  J Cell Physiol       Date:  2018-06-22       Impact factor: 6.384

3.  Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.

Authors:  Sylvia Fitting; Pamela E Knapp; Shiping Zou; William D Marks; M Scott Bowers; Hamid I Akbarali; Kurt F Hauser
Journal:  J Neurosci       Date:  2014-09-17       Impact factor: 6.167

4.  Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.

Authors:  Christina J Schier; William D Marks; Jason J Paris; Aaron J Barbour; Virginia D McLane; William F Maragos; A Rory McQuiston; Pamela E Knapp; Kurt F Hauser
Journal:  J Neurosci       Date:  2017-05-04       Impact factor: 6.167

Review 5.  HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.

Authors:  Xiu-Ti Hu
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

6.  Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K+ current.

Authors:  Jianuo Liu; Enquan Xu; Guihua Tu; Han Liu; Jiangtao Luo; Huangui Xiong
Journal:  Mol Cell Neurosci       Date:  2017-05-25       Impact factor: 4.314

7.  Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter.

Authors:  Yaxia Yuan; Xiaoqin Huang; Narasimha M Midde; Pamela M Quizon; Wei-Lun Sun; Jun Zhu; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2015-02-19       Impact factor: 4.418

Review 8.  HIV, Tat and dopamine transmission.

Authors:  Peter J Gaskill; Douglas R Miller; Joyonna Gamble-George; Hideaki Yano; Habibeh Khoshbouei
Journal:  Neurobiol Dis       Date:  2017-04-27       Impact factor: 5.996

9.  Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.

Authors:  Changqing Xu; Douglas J Hermes; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  J Neuroimmune Pharmacol       Date:  2016-03-18       Impact factor: 4.147

10.  Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat.

Authors:  Charles Adeniran; Yaxia Yuan; Sarah E Davis; Ciai Lin; Jiahui Xu; Jun Zhu; Chang-Guo Zhan
Journal:  ACS Chem Neurosci       Date:  2021-04-22       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.